               SEQUENCE LISTING

<110> Merck Patent GmbH

<120> TLR7/8 ANTAGONISTS AND USES THEREOF

<130> p 17/285

<140> USPCT/US2018/065112
<141> 2018-12-12

<150> US62/607,406
<151> 2017-12-19

<160> 4

<170> BiSSAP 1.3.6

<210> 1
<211> 22
<212> RNA
<213> Artificial Sequence


<220> 
<223> miRNA

<400> 1
ugagguagua gguuguaugg uu                                             22


<210> 2
<211> 22
<212> RNA
<213> Artificial Sequence


<220> 
<223> miRNA

<400> 2
ugagguagga gguuguauag uu                                             22


<210> 3
<211> 48
<212> RNA
<213> Artificial Sequence


<220> 
<223> miRNA

<400> 3
uuuuuuuuuu uuuuuuuuuu uuuugagacg gagucucgcu cugucgcc                  48


<210> 4
<211> 15
<212> RNA
<213> Artificial Sequence


<220> 
<223> miRNA

<400> 4
guuguguugu guugu                                                     15


